摘要:
The present invention refers to the use of 5-methyltetrahydrofolic acid, of 5-formyltetrahydrofolic acid and of their pharmaceutically acceptable salts for the preparation of controlled release pharmaceutical compositions suitable for the use in the therapy of depressive disturbances, in particular major depression, dysthymia or depressive neurosis and not otherwise specified depressive disturbances, independently from folate plasmatic levels, and to the pharmaceutical composition thus prepared.
摘要:
New carnitine salts with sulphonic acids, of general formula: in which R is a linear or branched alkyl chain of 8 to 18 carbon atoms, and which are particularly suitable for oral use. Said salts are prepared by the following stages:
a) preparing an aqueous solution of carnitine inner salt; b) preparing an aqueous solution of a sulphonic acid of formois RSO 3 H in which R has the aforesaid meaning; c) rescling the carnitine inner salt with the sulphonic acid in aqueous solution, and recovering the salt produced by oryin the solution.
摘要:
New cytidine-diphosphocholine (CDP-choline) salts with long-alkyl chain sulphonic acids suitable for injectable pharmaceutical formulations, but more specifically for oral formulations. Said salts are prepared by a process comprising preparing an aqueous solution of basic CDP-choline, preparing an aqueous sulphonic acid solution, reacting these two solutions together to obtain the required salt, and recovering this salt with a high degree of purity.
摘要:
New injectable aqueous therapeutic compositions based on stable SAMe salts and of pH between 5 and 8.5 are described. The compositions are characterised by the presence of an amino acid and an alkaline base in critical determined proportions with respect to the SAMe ion.
摘要:
New injectable aqueous therapeutic compositions based on stable SAMe salts and of pH between 5 and 8.5 are described. The compositions are characterised by the presence of an amino acid and an alkaline base in critical determined proportions with respect to the SAMe ion.
摘要:
S-adenosylmethionine salts have been prepared wich are stable even at elevated temperatures for practically indefinite time periods, and which correspond to the formula in which X is the acid equivalent of a strong mineral acid of pK less than 2.5, and n is 4, 5 or 6. The new salts are practically free from toxicity, and find application in numerous fields of human therapy.
摘要:
For the therapy of neurological complications in AIDS sufferers, the use of pharmaceutical compositions containing as an active principle at least one compound selected from the group consisting of S-adenosyl-L-methionine salt, 5-methyl-tetrahydro-folic acid, 5-formyltetrahydro-folic acid, when the active principle consists of S-adenosyl-L-methionine and of a derivative of tetrahydro folic acid, the weight ratio between the S-adenosyl-L-methionine salt and 5-methyltetrahydrofolic acid or 5-formyl-tetrahydrofolic acid is comprised between 10/1 and 4/1, in pharmaceutical form, suitable for oral or parenteral administration.